France on Friday mentioned beneath 55s who acquired a primary injection of the AstraZeneca Covid-19 vaccine must be given a jab from a special producer for his or her second dose, a ruling affecting greater than 500,000 folks.
France‘s nationwide well being authority HAS final month mentioned the AstraZeneca vaccine ought to solely be given to these aged 55 and over due to studies of doubtless lethal blood clots in a really small variety of these youthful folks vaccinated.
Officers in France initially mentioned that these given the AstraZeneca jab in a primary dose ought to go forward with the second jab even when aged beneath 55.
However the HAS mentioned that these aged beneath 55 who had been given the AstraZeneca as their first dose would now get the Pfizer-BioNTech or Moderna vaccine as their second course.
France has been injecting well being employees as a precedence group that means that many youthful folks have already acquired the AstraZeneca jab.
Some 533,000 individuals are affected by the choice, the HAS mentioned.
They embody Well being Minister Olivier Véran, a neurologist aged 41, who was given the AstraZeneca vaccine stay on tv on February 8.
“It’s utterly constant to say that we don’t advocate the AstraZeneca vaccine to folks beneath 55 years of age whereas we study extra,” the minister advised RTL.
“Subsequently, when you have acquired a primary injection and are beneath 55 years outdated, you’ll be provided one other vaccine 12 weeks after the primary injection.”
‘Information to be damaged’
Europe’s medicines regulator mentioned this week the AstraZeneca vaccine might trigger very uncommon blood clots amongst some recipients, prompting a number of international locations to scale up restrictions on the jab.
A number of scientific trials are wanting on the efficacy of mixing two kinds of vaccine.
“Primarily based on earlier research which mix completely different vaccine sorts, a mixture of the AZ and Pfizer vaccines is more likely to be protected nevertheless it’s essential that that is examined within the context of a scientific vaccine trial,” mentioned Helen Fletcher, professor of Immunology on the London College of Hygiene and Tropical Medication.
The WHO at the moment recommends the identical product be used for each doses however has mentioned additional analysis must be carried out on the interchangeability of vaccines in so-called “combine and match” methods.
After a sluggish begin, France’s vaccine marketing campaign is now gaining tempo and Prime Minister Jean Castex mentioned Thursday over 10 million folks within the nation had now acquired a minimum of their first dose.
Veran mentioned a report 437,000 folks had been injected in France on Thursday alone. “Information are made to be damaged and we’ll transcend that within the subsequent days,” he mentioned.